Monocytes and Fibrinogen as Biomarkers in Type 2 Diabetes Mellitus
Main Article Content
Abstract
Background: In the diagnosis of diabetic foot, in addition to the inflammatory biomarkers that have been widely interested and used, for example procalcitonin, C-reactive protein (CRP), ESR, leukocyte count, neutrophil count, Fibrinogen and Monocytes are considered as biomarkers in this study. possible.
Methods: A prospective study was designed to examine the utility of fibrinogen and monocytes in estimating disease severity in patients with DFU (Diabetic Foot Ulcer). The severity of DFU was assessed using the Wagner criteria distinguishing between patients with diabetic foot without ulcer (WDFU) and with non-infected diabetic foot ulcer (NIDFU) or with infected ulcer (IDFU). In this study the AA also wanted to correlate HbA1c to the concentration of Fibrinogen and the appearance of DFU, as well as the level of lymphocytes and monocyte precursors of macrophages in the evolution of ulcerated and non-ulcerated diabetic feet.
Results: Mean blood fibrinogen values were significantly higher in patients with DFU grade ≧2 compared to those with DFU grade ≤1 (424.4±138.8 mg/dL versus 395.3±130.0 mg/dL; p=0.091). Fibrinogen values were correlated with CRP levels, neutrophils, ESR and leukocyte count. Monocytes presented a significant difference between non-diabetic patients with ulcer and without ulcer (0.41 vs 0.29 k/L; p=0.000) and between the diabetic without ulcer (WDFU) and non-diabetic without ulcer (NDWU) groups (0.39 vs 0.29 k/L; p=0.000). The Procalcitonin (PCT) value was <0.5 ng/dl, therefore it had no diagnostic significance. Only 1% of the values found were higher than 0.5 with an average of 1.04 ng/dl (range: 0.52-2.5).
Conclusions: Neither monocytes nor HbA1c can be considered biomarkers for the risk of ulcer formation in the diabetic foot, but only as biomarkers of type 2 Diabetes Mellitus. Differently, fibrinogenemia, its pre/post intervention ratio, the angle and the k value of thromboelastography (TEG), have a clinical significance on the risk of onset and development of ulcerated diabetic foot.
The cut-off for ulcer formation for both the pre/post intervention ratio of fibrinogenemia and monocythemia is 1.10, with a sensitivity of 84.1% and a specificity of 24.5% for fibrinogen and 93.8% and 14.8% for monocytes.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Wang Y, Shao T, Wang J, Huang X, Deng X, Cao Y, Zhou M, Zhao C, An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage, Biomedicine & Pharmacotherapy,2021, 133, 110991,
https://doi.org/10.1016/j.biopha.2020.110991
II. Rehak, L. et al. The Immune-Centric Revolution in the Diabetic Foot : Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration — A Narrative Review. J Clin Med 11, 889 (2022). https://doi.org/10.3390/jcm11030889
III. Li, X. H., Guan, L. Y., Lin H. Y., et al., Fibrinogen: a marker in predicting diabetic foot ulcer severity, Journal of Diabetes Research, 2016, https://doi.org/10.1155/2016/2358321
IV. Mills J.L. et al., The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI), Journal of Vascular Surgery, 2014, 59, 220-234, http://dx.doi.org/10.1016/j.jvs.2013.08.003
V. Aziz Z, Lin WK, Nather A, Huak CY. Predictive factors for lower extremity amputations in diabetic foot infections. Diabet Foot Ankle. 2011;2. https://doi.org/10.3402/dfa.v2i0.7463.
VI. Korkmaz P, Kocak H, Onbasi K, Bicici P, Ozmen A, Uyar C, Ozatag DM, The role of serum procalcitonin, interleukin-6, and fibrinogen levels in differential diagnosis of diabetic foot ulcer infection, J. Diabetes Res. 2018, 7104352, https://doi.org/10.1155/2018/7104352.
VII. Crisci A., Crisci M., Boccalone E., Final results of an experimental research about a technique of measurement of skin lesions, Esperienze Dermatologiche, 2014, 16(6), 147-152;
VIII. Swarnakar R., Rahman H., Venkataraman S., Platelet-Rich Fibrin Membrane-as a novel biomaterial for pressure injury healing in a person with spinal cord injury: A case report, Spinal Cord Series and Cases, 2022, 8, 75, https://doi.org/10.1038/s41394-022-00540-8
IX. Stotts NA, Rodeheaver GT, Thomas DR, Frantz RA, Bartolucci AA, Sussman C, Ferrell BA, Cuddigan J, Maklebust J. An instrument to measure healing in pressure ulcers: development and validation of the pressure ulcer scale for healing (PUSH). J Gerontol A Biol Sci Med Sci. 2001 Dec;56(12):M795-9.
X. Crisci A., Il Piede Diabetico: Nuove prospettive di prevenzione e cure, Aracne Ed. Roma, 2015.
XI. Valencia L, PCT testing in sepsis protocols, Front. Anal. Sci., 2023, 3:1229003, https://doi.org/10.3389/frans.2023.1229003
XII. Aldana C.A., Amenabar F.U., Silva C.I., et al., The impact of gender and peripheral blood parameters on the characteristics of L-PRF membranes, Journal of Oral Biology and Craniofacial Research, 2022, 12, 6, 753-759, https://doi.org/10.1016/j.jobcr.2022.08.020
XIII. Akoglu H., User’s guide to correlation coefficients, Turk J Emerg Med, 2018, 18 (3):91-93. https://doi.org/10.1016/j.tjem.2018.08.001
XIV. Ramanujam V, Di Maria S, Varma V. Thromboelastography in the Perioperative Period: A Literature Review. Cureus. 2023 May 23;15(5):e39407. https://doi.org/10.7759/cureus.39407
XV. Zhang J, Lin J, Liang B, Chen L, Yang X, Li M., Fibrinogen function indexes are potential biomarkers for evaluating the occurrence and severity of diabetic foot, Diabetol Metab Syndr., 2022, 14(1): 182 https://doi.org/10.1186/s13098-022-00960-4.
XVI. Kunutsor S. K., Kurl S., Zaccardi F., Laukkanen J. A. Baseline and long-term fibrinogen levels and risk of sudden cardiac death: a new prospective study and meta-analysis. Atherosclerosis. 2016;245:171–180. https://doi.org/10.1016/j.atherosclerosis.2015.12.020.
XVII. Casado-Diaz A, Stem Cells in regenerative Medicine, J.Clin.Med., 2022, 11, 5460, https://doi.org/10.3390/jcm11185460
XVIII. Caravaggio, F., Antonelli, M. & Depalmi, F. Regenerative medicine: potential applications for foot and ankle disorders. Lo Scalpello - Otodi Educ. 35, 117–128 (2021).